Clinical Trials on ALK-negative Anaplastic Large Cell Lymphoma
Total 7375 results
-
Samsung Medical CenterJanssen, LPUnknown
-
First Affiliated Hospital of Zhejiang UniversityUnknown
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedDiffuse, Large B-Cell, LymphomaChina
-
Shanghai YingLi Pharmaceutical Co. Ltd.UnknownDiffuse Large B Cell Lymphoma
-
Kosin University Gospel HospitalCompletedDiffuse Large B-cell Lymphoma
-
The First Affiliated Hospital with Nanjing Medical...Nanjing Bioheng Biotech Co., Ltd.UnknownDiffuse Large B-cell LymphomaChina
-
mAbxience Research S.L.Laboratorio Elea Phoenix S.A.; Libbs Farmacêutica LTDA; Innogene Kalbiotech Pte... and other collaboratorsCompletedDiffuse Large B-cell LymphomaMalaysia, Argentina, Colombia, India, South Africa, Philippines, Brazil, Russian Federation, Indonesia, Iran, Islamic Republic of, Mexico, Paraguay
-
The First Affiliated Hospital with Nanjing Medical...UnknownDiffuse Large B-cell Lymphoma
-
Grupo Español de Linfomas y Transplante Autólogo...Janssen-Cilag, S.A.CompletedDiffuse, Large B-Cell, LymphomaSpain
-
Mingzhi ZhangUnknownDiffuse Large B Cell LymphomaChina
-
Weill Medical College of Cornell UniversityBristol-Myers SquibbTerminatedDiffuse Large B-cell LymphomaUnited States
-
Lymphoma Study AssociationCompletedLymphoma, Non-Hodgkin | Diffuse Large B-cell LymphomaBelgium, France
-
Mingzhi ZhangUnknownDiffuse Large B Cell LymphomaChina
-
SanofiCompletedDiffuse Large B-cell LymphomaBelgium, Israel, Spain, Czechia, Turkey, Italy, United States, Poland, United Kingdom
-
Asan Medical CenterEnrolling by invitation
-
Asan Medical CenterEnrolling by invitation
-
Xinjiang Medical UniversityUnknownDiffuse, Large B-Cell, LymphomaChina
-
Mansoura UniversityUnknown
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical CenterTerminatedDiffuse Large B Cell LymphomaUnited States
-
Hebei Medical University Fourth HospitalUnknownDiffuse Large B-cell LymphomaChina
-
University Hospital, CaenUnknownDiffuse Large B Cell Lymphoma
-
National Cancer Centre, SingaporeGlaxoSmithKlineCompletedDiffuse Large B-cell LymphomaSingapore
-
Asan Medical CenterWithdrawnDiffuse Large B-cell LymphomaKorea, Republic of
-
Samsung Medical CenterNational Cancer Center, Korea; Asan Medical Center; Korea University; Yonsei University and other collaboratorsCompletedDiffuse Large B-cell LymphomaKorea, Republic of
-
Massachusetts General HospitalNovartis; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical CenterCompletedDiffuse Large B-cell LymphomaUnited States
-
Fudan UniversityTerminated
-
Fondazione Italiana Linfomi ONLUSUnknownDiffuse Large B-cell LymphomaItaly
-
Nantes University HospitalCompletedLymphoma, Large-Cell, DiffuseFrance
-
Fudan UniversityUnknown
-
Lymphoma Study AssociationAmgenCompletedDiffuse Large-Cell LymphomaFrance, Belgium
-
Chulalongkorn UniversityBayerTerminatedDiffuse Large B-cell LymphomaThailand
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Anhui Provincial Hospital; The First People's Hospital of Hefei; Hefei Binhu...UnknownFollicular Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Acute Lymphocytic Leukemia | Diffuse Large Cell Lymphoma | B-cell Prolymphocytic LeukemiaChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Refractory Mantle Cell Lymphoma | Transformed Follicular Lymphoma to Diffuse Large B-Cell LymphomaUnited States
-
University of Alabama at BirminghamNot yet recruitingLymphoma, Follicular | Lymphoma, B-Cell | Diffuse Large B Cell LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)TerminatedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | CD20 PositiveUnited States
-
AstraZenecaWithdrawnCore: Relapsed or Refractory Diffuse Large B-Cell Lymphoma | Module 1: Non-GCB Diffuse Large B-Cell Lymphoma
-
Xinqiao Hospital of ChongqingXuzhou Medical UniversityUnknownRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Follicular Lymphoma | Stage III/IV Adult Diffuse Large Cell Lymphoma | Stage III/IV Follicular Lymphoma | Stage III/IV Mantle Cell LymphomaChina
-
The Lymphoma Academic Research OrganisationActive, not recruitingRefractory Indolent Adult Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Diffuse Large B-Cell Lymphoma Refractory | Refractory Transformed B-cell Non-Hodgkin Lymphoma | Refractory Primary Mediastinal Large B-Cell Cell LymphomaFrance
-
National Cancer Institute (NCI)RecruitingHigh Grade B-Cell Lymphoma | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell LymphomaUnited States
-
Beijing Yongtai Ruike Biotechnology Company LtdRecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-cell LymphomaChina
-
RenJi HospitalRecruitingDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B Cell Lymphoma RefractoryChina
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
Mehrdad Abedi, MDNational Cancer Institute (NCI)RecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
Emory UniversityNational Cancer Institute (NCI); Novartis; Secura Bio, Inc.RecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
WepromRecruitingDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaFrance
-
AmgenMerck Sharp & Dohme LLCCompletedRelapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)United States, Germany, Spain, Australia, Netherlands, France
-
ADC Therapeutics S.A.CompletedDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B-Cell Lymphoma RefractoryUnited States, United Kingdom, Italy, Switzerland
-
Fondazione Italiana Linfomi ONLUSJanssen Pharmaceutica; Janssen-Cilag Ltd.; Centro di Riferimento per l'Epidemiologia...CompletedDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B-cell Lymphoma RefractoryItaly
-
Fondazione Italiana Linfomi ONLUSCompletedDiffuse Large B Cell Lymphoma (DLBCL) | Elderly Patients (>65 Years)Italy